These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6509455)

  • 1. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative study.
    Smyth JF; Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):15-8. PubMed ID: 6484578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of spirogermanium in advanced breast cancer.
    Kuebler JP; Tormey DC; Harper GR; Chang YC; Khandekar JD; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase II study of mitoxantrone in advanced breast cancer.
    Pronzato P; Ardizzoni A; Conte PF; Gulisano M; Lionetto R; Repetto L; Scornavacche V; Sertoli MR; Rosso R
    Chemioterapia; 1986 Jun; 5(3):150-3. PubMed ID: 3719852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.
    Davis RB; Van Echo DA; Leone LA; Henderson ES
    Cancer Treat Rep; 1986 Sep; 70(9):1125-6. PubMed ID: 3742493
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential cardiotoxicity with mitoxantrone.
    Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
    Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project.
    Smalley R; Gams R
    Cancer Treat Rep; 1983 Nov; 67(11):1039-40. PubMed ID: 6640553
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
    Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ; Terblanche AP
    Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
    [No Abstract]   [Full Text] [Related]  

  • 19. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
    Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
    J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.